Published in Br J Clin Pharmacol on September 01, 2000
Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res (2003) 1.01
Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther (2008) 0.83
Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil (2008) 0.83
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clin Exp Gastroenterol (2012) 0.82
Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.80
Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agent. Br J Clin Pharmacol (2010) 0.79
Kappa Opioid Receptor Agonist and Brain Ischemia. Transl Perioper Pain Med (2014) 0.77
Involvement of opioid peptides and arginine-vasopressin in the regulation of water-electrolyte exchange in the amoeba Amoeba proteus. Dokl Biol Sci (2004) 0.75
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. J Pharmacol Exp Ther (1983) 2.65
Kappa-opioid receptors and analgesia. Trends Pharmacol Sci (1990) 1.49
Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther (1987) 1.25
Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther (1988) 1.17
Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine. J Pharmacol Exp Ther (1982) 1.13
Diuretic actions in man of a selective kappa opioid agonist: U-62,066E. J Pharmacol Exp Ther (1987) 1.08
A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol (1994) 1.06
Inhibition of ADH release in the rat by narcotic antagonists. Neuroendocrinology (1975) 1.04
On the mechanisms of kappa-opioid-induced diuresis. Br J Pharmacol (1986) 1.01
Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther (1987) 0.95
Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine. J Pharmacol Exp Ther (1985) 0.93
Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis. J Pharmacol Exp Ther (1993) 0.92
Symbols in pharmacokinetics. J Pharmacokinet Biopharm (1980) 0.91
Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog. J Pharmacol Exp Ther (1984) 0.90
Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis. Neuroendocrinology (1988) 0.88
Kappa-opioid-induced changes in renal water and electrolyte management and endocrine secretion. Br J Pharmacol (1989) 0.87
Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers. J Pharmacol Exp Ther (1996) 0.84
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. J Clin Pharmacol (1994) 0.84
Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats. Br J Pharmacol (1989) 0.83
Mechanism of diuretic action of spiradoline (U-62066E)--a kappa opioid receptor agonist in the human. Br J Clin Pharmacol (1991) 0.83
Characteristics of endothelin receptors and intracellular signalling in porcine inner medullary collecting duct cells. Am J Hypertens (1993) 0.83
Displacement of 3H-EKC binding by opioids in rat kidney: a correlate to diuretic activity. Life Sci (1985) 0.83
Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther (1989) 0.83
Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats. Br J Pharmacol (1990) 0.81
Role of ADH in ethylketocyclazocine-induced diuresis: studies in the Brattleboro rat. Life Sci (1986) 0.81
Kappa agonists and vasopressin secretion. Horm Res (1990) 0.80
Diuretic action of the narcotic antagonist oxilorphan. Clin Pharmacol Ther (1974) 0.79
Aquaretic effect of the stable dynorphin-A analog E2078 in the human. J Pharmacol Exp Ther (1994) 0.78
Kappa-opioid modulation of vasopressin secretion in conscious rats. J Endocrinol (1991) 0.77
Atrial natriuretic hormones. Gen Pharmacol (1988) 0.77
Atrial natriuretic peptide and endothelin: modulators of renal function. Clin Investig (1994) 0.77
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg (2000) 2.73
Management of acute pancreatitis: from surgery to interventional intensive care. Gut (2005) 2.02
Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg (1995) 1.94
Late mortality in patients with severe acute pancreatitis. Br J Surg (2001) 1.92
Who reads temporal information contained across synchronized and oscillatory spike trains? Nature (1998) 1.70
The role of infection in acute pancreatitis. Gut (1999) 1.66
Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head? Langenbecks Arch Surg (2012) 1.49
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg (2005) 1.42
Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg (2001) 1.31
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
Surgical treatment of infected necrosis. World J Surg (1997) 1.25
Double sigmoid colon perforation by a migrated biliary stent. Acta Chir Belg (2008) 1.21
Distribution of lesions and antigen of highly pathogenic avian influenza virus A/Swan/Germany/R65/06 (H5N1) in domestic cats after presumptive infection by wild birds. Vet Pathol (2007) 1.21
Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain (1998) 1.10
Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut (1996) 1.09
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia (2012) 1.08
Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin Sci (Lond) (1980) 1.08
Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut (1997) 1.07
The renal endothelin system in the Prague hypertensive rat, a new model of spontaneous hypertension. Clin Sci (Lond) (1999) 1.06
Prevention and treatment of complications in pancreatic cancer surgery. Dig Surg (1999) 1.02
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Ann Oncol (2011) 1.00
The role of octreotide in the prevention of complications following pancreatic resection. Digestion (1999) 1.00
Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol (1986) 0.98
A modified technique of the Beger and Frey procedure in patients with chronic pancreatitis. Dig Surg (2001) 0.98
Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg (1998) 0.97
Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut (2000) 0.97
Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice. J Invest Surg (2007) 0.97
Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia (2008) 0.95
[Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis--results of a prospective clinical study]. Z Gastroenterol (1986) 0.94
Inhibition of intestinal (Na+--K+)-ATPase in experimental uremia. Clin Chim Acta (1974) 0.92
Specimen retrieval in laparoscopic colon surgery. Dig Surg (2002) 0.91
Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int J Pancreatol (1993) 0.91
The role of surgery in the management of acute pancreatitis. Can J Gastroenterol (2000) 0.91
[Surgical therapy of ileus of the large intestine]. Zentralbl Chir (1998) 0.89
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig (1994) 0.89
'One also needs a bit of trust in the doctor ... ': a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann Oncol (2013) 0.88
Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis. Gut (1999) 0.88
Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. Dig Dis Sci (2001) 0.87
Pancreatic necrosis: an early finding in severe acute pancreatitis. Pancreas (1993) 0.87
The clinical value of human pancreas-specific protein procarboxypeptidase B as an indicator of necrosis in acute pancreatitis: comparison to CRP and LDH. Pancreas (1998) 0.86
Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut (2002) 0.86
Effect of a pneumoperitoneum on systemic cytokine levels, bacterial translocation, and organ complications in a rat model of severe acute pancreatitis with infected necrosis. Surg Endosc (2006) 0.85
Rat renal, aortic and pulmonary endothelin-I receptors: effects of changes in sodium and water intake. Clin Sci (Lond) (1993) 0.85
Complicated sigmoid diverticulitis--Hartmann's procedure or primary anastomosis? Acta Chir Belg (2012) 0.85
TME quality in rectal cancer surgery. Eur J Med Res (2010) 0.85
[(section sign) 115 b SGB V threatens outpatient treatment for inguinal hernia. Analysis of outcome and economics]. Chirurg (2006) 0.84
Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut (2002) 0.84
Removal of geosmin and MIB by biofiltration--an investigation discriminating between adsorption and biodegradation. Environ Technol (2007) 0.84
The influence of renal function on NT-proBNP levels in various disease groups. Clin Lab (2003) 0.84
Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy. HPB Surg (2010) 0.84
Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am J Hypertens (1997) 0.84
Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis. Eur Surg Res (2008) 0.84
[Surgical therapy of diffuse peritonitis: debridement and intraoperative extensive lavage]. Chirurg (1997) 0.83
Characteristics of endothelin receptors and intracellular signalling in porcine inner medullary collecting duct cells. Am J Hypertens (1993) 0.83
Clinical relevance of experimental acute pancreatitis. Eur Surg Res (1992) 0.83
Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells. J Invest Surg (2007) 0.83
Diagnostic value of quantitative EUS elastography for malignant pancreatic tumors: relationship with pancreatic fibrosis. Ultraschall Med (2011) 0.83
Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas (1995) 0.83
Serum phospholipase A2 in patients with multiple organ failure. J Surg Res (1996) 0.83
[Coexistence of multifocal gastric adenocarcinoma with signet-ring cell morphology and a gastrointestinal stromal tumour in a stomach with hp-associated gastritis]. Z Gastroenterol (2011) 0.82
Phospholipase A2 isoforms are altered in chronic pancreatitis. Ann Surg (1998) 0.82
[Acute pancreatitis--clinical and technical laboratory diagnostic and prognostic assessment]. Swiss Surg (2000) 0.82
Endothelin synthesis by porcine inner medullary collecting duct cells. Effects of hormonal and osmotic stimuli. Am J Hypertens (1995) 0.82
Selective downregulation of rat renal clearance receptors for atrial natriuretic peptide by chronic high-salt intake: study on isolated membranes using 125I-labelled c-atrial natriuretic peptide-(4-23). Clin Sci (Lond) (1992) 0.82
Effects of endothelin on sodium transport mechanisms: potential role in cellular Ca2+ mobilization. Biochem Biophys Res Commun (1989) 0.82
On the conformation of 5-substituted uridines as studied by proton magnetic resonance. Nucleic Acids Res (1983) 0.82
Metastatic angiosarcoma of the liver preoperatively presenting as giant hemangioma. Digestion (2000) 0.82
Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase. Am J Hypertens (1995) 0.81
Characterization of two phospholipases A2 in serum of patients with sepsis and acute pancreatitis. Eur J Clin Chem Clin Biochem (1992) 0.81
Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany. Digestion (1994) 0.81
Determinants of glucose control in patients with chronic pancreatitis. Diabetologia (2010) 0.81
Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct. Clin Exp Hypertens (1998) 0.81
Renal endothelin system in obstructive jaundice: its role in impaired renal function of bile-duct ligated rats. Clin Sci (Lond) (1997) 0.81
Pharmacokinetics of Fem7, a once-weekly, transdermal oestrogen replacement system in healthy, postmenopausal women. Gynecol Obstet Invest (1999) 0.81
Cellular mechanisms of action of a ouabain-like factor in vascular smooth-muscle cells. J Cardiovasc Pharmacol (1993) 0.81
[Technical aspects of pancreatoenteric anastomosis]. Chirurg (2011) 0.80
Changing concepts in the surgical management of acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol (1999) 0.80
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Physiol Res (2004) 0.80
Effects of urinary ouabain-like factors and vanadium diascorbate on calcium mobilization in porcine inner medullary collecting duct cells: comparison with the effects of ouabain and vasopressin. Am J Hypertens (1998) 0.80
Severe acute pancreatitis. II: the surgical approach. Clin Intensive Care (1990) 0.80
Hyperosmolality induced by betaine or urea stimulates endothelin synthesis by differential activation of ERK and p38 MAP kinase in MDCK cells. Kidney Blood Press Res (2002) 0.80
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. Anticancer Res (2012) 0.80
[Acute pancreatitis: surgical therapy]. Praxis (Bern 1994) (2005) 0.80
End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade. Physiol Res (2009) 0.80
Duodenum-preserving resection of the head of the pancreas--an alternative to Whipple's procedure in chronic pancreatitis. Hepatogastroenterology (1990) 0.80
Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. Digestion (1994) 0.80
Human pancreas-specific protein. A diagnostic and prognostic marker in acute pancreatitis and pancreas transplantation. Int J Pancreatol (1996) 0.80
Phospholipase A2 isoforms in acute pancreatitis. Ann Surg (2001) 0.80
Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial. Scand J Surg (2013) 0.80
Vanadium-diascorbates are strong candidates for endogenous ouabain-like factors in human urine: effects on Na-K-ATPase enzyme kinetics. Biochem Biophys Res Commun (1995) 0.79
Complications of acute pancreatitis and their management. Curr Opin Gen Surg (1993) 0.79
Carboxylic ester hydrolase. A sensitive serum marker and indicator of severity of acute pancreatitis. Int J Pancreatol (1991) 0.79
Antinatriferic activity in human plasma following acute and chronic salt-loading. Kidney Int (1977) 0.79
Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis. Klin Wochenschr (1989) 0.79
Further characterization of the endogenous natriuretic and digoxin-like immunoreacting activities in human urine: effects of changes in sodium intake. Ren Physiol (1985) 0.79
Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. Drug Metab Dispos (2001) 0.79
[R classification and pancreatic ductal adenocarcinoma--R 0 is R 0]. Z Gastroenterol (2011) 0.78